Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Pickhard

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Oncotarget|July 2, 2014
The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphismAnja Pickhard, Michael Siegl, Alexander Baumann, et al.
American Journal of Cancer Research|October 12, 2016
HNSCC cells resistant to EGFR pathway inhibitors are hypermutated and sensitive to DNA damaging substancesDominik Schulz, Markus Wirth, Guido Piontek, et al.
Oncotarget|September 24, 2014
Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR / SphK1 crosstalkCarlotta Schiefler, Guido Piontek, Johannes Doescher, et al.
Cancers|February 25, 2022
NOTCH1 Intracellular Domain and the Tumor Microenvironment as Prognostic Markers in HNSCCBenedikt Schmidl, Michael Siegl, Melanie Boxberg, et al.
Nuclear Medicine and Biology|November 12, 2013
²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cellsAnja Pickhard, Guido Piontek, Christof Seidl, et al.
Oncotarget|April 22, 2017
Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiationDominik Thomas Koch, Anja Pickhard, Lena Gebel, et al.
American Journal of Medical Genetics. Part A|February 19, 2015
A post GWAS association study of SNPs associated with cleft lip with or without cleft palate in submucous cleft palateRudolf Reiter, Sibylle Brosch, Ingrid Goebel, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 28, 2022
Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinomaBenedikt Schmidl, Kim-Aylin Voßenkämper, Leonhard Stark, et al.
Cancers|June 2, 2021
Radiooncological View on Therapy Outcome after Multidisciplinary Treatment of Sinonasal TumorsOlena Klymenko, Anna Maria Stefanie Buchberger, Barbara Wollenberg, et al.
Oncotarget|March 22, 2018
The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinomaAlexander Baumann, Anna Maria S Buchberger, Guido Piontek, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Oncotarget|July 2, 2014
The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphismAnja Pickhard, Michael Siegl, Alexander Baumann, et al.
American Journal of Cancer Research|October 12, 2016
HNSCC cells resistant to EGFR pathway inhibitors are hypermutated and sensitive to DNA damaging substancesDominik Schulz, Markus Wirth, Guido Piontek, et al.
Oncotarget|September 24, 2014
Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR / SphK1 crosstalkCarlotta Schiefler, Guido Piontek, Johannes Doescher, et al.
Cancers|February 25, 2022
NOTCH1 Intracellular Domain and the Tumor Microenvironment as Prognostic Markers in HNSCCBenedikt Schmidl, Michael Siegl, Melanie Boxberg, et al.
Nuclear Medicine and Biology|November 12, 2013
²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cellsAnja Pickhard, Guido Piontek, Christof Seidl, et al.
Oncotarget|April 22, 2017
Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiationDominik Thomas Koch, Anja Pickhard, Lena Gebel, et al.
American Journal of Medical Genetics. Part A|February 19, 2015
A post GWAS association study of SNPs associated with cleft lip with or without cleft palate in submucous cleft palateRudolf Reiter, Sibylle Brosch, Ingrid Goebel, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 28, 2022
Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinomaBenedikt Schmidl, Kim-Aylin Voßenkämper, Leonhard Stark, et al.
Cancers|June 2, 2021
Radiooncological View on Therapy Outcome after Multidisciplinary Treatment of Sinonasal TumorsOlena Klymenko, Anna Maria Stefanie Buchberger, Barbara Wollenberg, et al.
Oncotarget|March 22, 2018
The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinomaAlexander Baumann, Anna Maria S Buchberger, Guido Piontek, et al.
Pageof 6